Nuvectra Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- Nuvectra's estimated annual revenue is currently $49.9M per year.
- Nuvectra's estimated revenue per employee is $251,000
- Nuvectra has 199 Employees.
- Nuvectra grew their employee count by 3% last year.
- Nuvectra currently has 1 job openings.
|Brad Pollard||Sales Director|
|Jennifer Kosharek||Interim Chief Financial Officer|
|Eric Hall||Co-founder, COO|
|Ted Cole||Territory Manager|
|Matt Long||Director Of Sales Training|
|Alberto Kan||Territory Sales Manager|
|Josh Valladon||Territory Manager|
|Jennifer Harris||Executive Director of Quality Assurance|
|John Taylor||Territory Manager|
What Is Nuvectra?
Nuvectra® is a neuromodulation company committed to helping physicians improve the lives of people with chronic conditions through our medical devices. At Nuvectra, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder and deep brain stimulation (DBS) for the treatment of Parkinson's Disease. NeuroNexus, a subsidiary owned by Nuvectra, designs, manufactures, and markets leading-edge neural-interface technologies for the neuroscience clinical research market.keywords:Healthcare,Medical Devices
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Emergo by UL||$61M||243||6%||N/A|
|MedInc of Texas...||$11M||44||42%||N/A|
|Draeger Safety ...||$9.8M||39||11%||N/A|
|Apple Homecare ...||$9.8M||39||18%||N/A|
|Acessa Health I...||$14.8M||59||64%||N/A|
PLANO, Texas, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NVTR), a neurostimulation medical device company, today ...
Nuvectra Corporation (NASDAQ:NVTR) is among the top gainers of the stock market today, skyrocketing 11.36% or (0.15 points) to $1.47 from ...
Gamco Investors INC. ET AL boosted its position in Nuvectra Corp (NASDAQ:NVTR) by 19.8% during the second quarter, Holdings Channel ...